Loading viewer...
report
Format: PDF report
This report presents findings from the ENIGMA trial, highlighting histologic and symptomatic improvements in eosinophilic gastrointestinal diseases treated with Antolimab.
presentation
report
Vaco
report
TOMRA Systems ASA
report
888 Holdings plc
report
AXIS Capital